Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,482.3
10.1 (0.41%)

 

  • STI Straits Times Index
    2,482.3
    10.1 (0.41%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,509.0
    -0.1 (-0.01%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,444.6
    209.1 (0.90%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,217.5
    -1.9 (-0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,511.6
    307.0 (1.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,918.5
    -27.3 (-0.55%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 532.1M
  • Value: 551.7M
  • Rise: 123
  • Fall: 141
  • Unch: 516

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.052+0.001
Vicplas Intl0.350-0.100
Sembcorp Marine0.143+0.001
OEL0.019+0.001
Synagie0.205-0.005
Singtel2.120-0.020
HPH Trust USD0.135+0.005
Oceanus^0.007-
ISDN0.410+0.010
ThaiBev0.600+0.015

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CSL CSL
Updated on 25 Sep 2020 (End of trading day)
Last (AUD): 296.710 Change: +0.230 High: 298.450 Remarks: -
Change (%): +0.08 Low: 294.630
Open 298.140 Yesterday's Close 296.47999999999996
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 537,927 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 6.89371 Trailing EPS (AUD) e 6.89371 NAV (AUD) b 20.8387
PE a 43.041 Trailing PE f 43.041 Price / NAV b 14.2384
Dividend (AUD) d 2.935004 Cash In Hand (AUD) g 3.8131 Issued & Paid-up Shares c 454,953,000
Dividend Yield (%) d 0.989 Price / Cash In Hand g 77.813 Treasury Shares h -
Beta - 75 Daysi 1.334 R-Squared - 75 Days(%)i 50.78 Market Cap (M) 134,989.105
Beta - 500 Daysi 1.300 R-Squared - 500 Days (%)i 37.01 Enterprise Value (M) 141,958.458
Piotroski F Score 5 Exchange Code CSL Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 28.96 Free Float (%) 99.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 23 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CSL ASX 134,989.105 43.041 43.041 14.2384 0.989
Industry Biotechnology ASX 3,827.381 49.868 50.216 13.3160 0.943
Local Peer MESOBLAST LTD ASX 2,862.957 - - 3.5884 -
Local Peer POLYNOVO LIMITED ASX 1,427.950 - - 60.0000 -
Local Peer TELIX PHARMACEUTIC ASX 430.435 - - 8.0142 -
Local Peer NEXT SCIENCE LTD ASX 229.620 - - 12.4110 -
Local Peer IMUGENE LIMITED ASX 215.594 - - 3.6090 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 135.249 - - 14.8771 -
Local Peer ANTEOTECH LIMITED ASX 125.710 - - 39.4737 -
Local Peer IMMUTEP LTD ASX 124.346 - - -15.2695 -
Local Peer BIONOMICS LTD ASX 122.570 - - 9.6774 -
Local Peer CYNATA THERAPEUTICS LTD ASX 119.466 - - 7.1130 -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 88.000 - - 6.2291 -
Local Peer INVEX THERAPEUTICS LTD NPV ASX 76.657 - - 3.1414 -
Other Local Peers MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), PATRYS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), NANOLLOSE LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 142,803.911 18.210 19.565 13.3975 2.402
Global Peer AMGEN-T HKEx 1,083,533.900 17.635 19.045 13.1159 2.480
Global Peer GILEAD SCIENCES INC NASDAQ 78,044.070 14.490 - 4.3293 4.088
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,852.040 59.357 33.570 9.2898 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,075.374 28.866 20.471 6.7431 -
Global Peer ILLUMINA INC NASDAQ 43,891.900 43.804 63.336 9.6191 -
Global Peer BIOGEN INC NASDAQ 43,263.777 7.347 7.300 3.8257 -
Global Peer SEATTLE GENETICS INC NASDAQ 32,180.745 - - 17.7395 -
Global Peer WUXI BIO HKEx 243,646.124 211.945 169.209 16.3106 -
Global Peer MODERNA INC NASDAQ 27,411.959 - - 9.3020 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), IMMUNOMEDICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), 10X GENOMICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), Lonza (SGX), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), GENSCRIPT BIO (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), 3SBIO (HKEx), ALKERMES PLC (NASDAQ), VAXCYTE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VIVA BIOTECH (HKEx), SERES THERAPEUTICS (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HAOHAI BIOTEC (HKEx), BENITEC BIOPHARMA INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), EDITAS MEDICINE INC (NASDAQ), ALPHAMAB-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), UNIQURE N.V. (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), VIELA BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), COMPUGEN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), NGM BIOPHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), RETROPHIN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FRONTAGE (HKEx), ALECTOR INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), AKOUOS INC (NASDAQ), PERSONALIS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VAXART INC (NASDAQ), ASCENTAGE-B (HKEx), NANTKWEST INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AGENUS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), KADMON HLDGS INC (NYSE), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), PRECIGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XBIOTECH INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), GERON CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), KINTOR PHARMA-B (HKEx), HUMANIGEN INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AVROBIO INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), IVERIC BIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ATRECA INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SINOMAB BIO-B (HKEx), CYMABAY THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ASCLETIS-B (HKEx), PREVAIL THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), LEE'S PHARM (HKEx), KAMADA (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ESSEX BIO-TECH (HKEx), MAGENTA THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), PFENEX INC (NYSE American), IMV INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), METACRINE INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), AFFIMED N V (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CABALETTA BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), ADICET BIO INC (NASDAQ), VERASTEM INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IBIO INC (NYSE American), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OTONOMY INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), EQUILLIUM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CEL-SCI CORP (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), PIERIS PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), UNI-BIO GROUP (HKEx), NEUROBO PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ARAVIVE INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), COHBAR INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), CURIS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), RECRO PHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), MIRAGEN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), OCUGEN INC (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), Suntar Eco-City (SGX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), REGENT PACIFIC (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), PLUS THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), HAO WEN HLDGS (HKEx), AURIS MEDICAL HOLDING LTD (NASDAQ), GEOVAX LABS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+14.090
+4.99 %
10 Days -+13.210
+4.66 %
20 Days -+6.820
+2.35 %
Medium Term Return 3 Months -+3.970
+1.36 %
6 Months -+17.590
+6.30 %
1 Year -+62.410
+26.64 %
Long Term Return 2 Years 1.203+95.600
+48.13 %
3 Years 2.481+162.750
+123.34 %
5 Years 5.936+208.170
+241.82 %
Annualised Return Annualised --
+27.87 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 227.260 - 342.750 Change From 1 Year Low +69.450 % Change From 1 Year Low (%) +30.56
Change From 1 Year High -46.040 % Change From 1 Year High (%) -13.43
2 Years Range 173.000 - 342.750 Change From 2 Years Low +123.710 % Change From 2 Years Low (%) +71.51
Change From 2 Years High -46.040 % Change From 2 Years High (%) -13.43
5 Years Range 88.020 - 342.750 Change From 5 Years Low +208.690 % Change From 5 Years Low (%) +237.09
Change From 5 Years High -46.040 % Change From 5 Years High (%) -13.43
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 298.140 298.450 294.630 296.710 537,927 -
24 Sep 2020 292.310 297.960 290.260 296.480 849,679 -
23 Sep 2020 289.510 298.000 288.540 297.210 1,053,372 -
22 Sep 2020 282.000 288.080 282.000 286.350 784,366 -
21 Sep 2020 284.800 287.920 282.620 283.250 608,272 -
18 Sep 2020 286.560 287.730 282.620 282.620 2,082,997 -
17 Sep 2020 290.060 291.300 285.700 285.720 976,179 -
16 Sep 2020 289.010 291.950 288.500 291.180 1,053,616 -
15 Sep 2020 285.000 288.770 284.710 287.240 940,756 -
14 Sep 2020 285.250 285.650 281.660 283.140 547,081 -
11 Sep 2020 280.280 284.500 279.850 283.500 565,634 -
10 Sep 2020 285.120 285.310 281.040 282.000 783,709 -
09 Sep 2020 280.520 285.590 279.000 281.000 991,217 -
08 Sep 2020 285.000 290.970 284.100 288.180 812,576 -
07 Sep 2020 285.000 286.870 279.010 282.130 778,476 -
04 Sep 2020 285.000 286.000 279.050 279.050 1,061,683 -
03 Sep 2020 293.500 294.280 288.650 290.950 681,187 -
02 Sep 2020 282.000 288.580 282.000 287.200 777,255 -
01 Sep 2020 285.000 287.230 279.910 281.680 1,081,584 -
31 Aug 2020 289.200 290.630 286.000 286.010 701,016 -
28 Aug 2020 292.510 293.850 288.100 289.890 911,273 -
27 Aug 2020 292.240 297.155 291.790 293.550 986,085 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)		 285.250 298.450 281.660 296.710 9,434,245 -
Previous 2 Weeks
(31 Aug 2020 to 11 Sep 2020)		 289.200 298.450 281.660 283.500 8,234,337 -
4 Weeks from
(03 Aug 2020 to 28 Aug 2020)		 270.000 298.450 268.680 289.890 21,266,590 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.